Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Information
- Disease name
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03677596 | Completed | Phase 4 | A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients | July 1, 2019 | May 26, 2023 |
| NCT00849147 | Completed | Phase 2 | Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603) | October 2008 | November 2013 |
| NCT00864227 | Completed | Phase 2 | Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604) | December 2008 | November 2013 |
| NCT00822432 | Completed | Coproporphyrine Isomers and Methotrexate Elimination | October 2007 | August 2011 | |
| NCT01116193 | Completed | Phase 2 | Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia | January 2010 | August 2013 |
| NCT01786096 | Completed | Phase 1 | A Safety Study of SGN-CD19A for Leukemia and Lymphoma | February 2013 | May 30, 2017 |
| NCT01786135 | Completed | Phase 1 | A Safety Study of SGN-CD19A for B-Cell Lymphoma | February 2013 | February 16, 2017 |
| NCT00905398 | Terminated | Phase 1/Phase 2 | Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | May 2009 | July 2015 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015452